Clinical trial
Assessing HIV Antibody Increases Following Viral Rebound in People Receiving Antiretroviral Therapy
NCT07665060 is registered in ClinicalTrials.gov with NYU Langone Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing HIV Antibody Increases Following Viral Rebound in People Receiving Antiretroviral Therapy
- Lead sponsor
- NYU Langone Health
- Phase
- Observational
- Overall status
- Active, not recruiting
- Start date
- April 1, 2026
- Completion date
- March 31, 2031
- Enrollment
- 6,100 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hiv